SB 78

Requiring certain providers and laboratories to provide certain written information to patients receiving prostate-specific antigen testing; and requiring clinical laboratories that administer prostate-specific antigen tests to follow certain disclosure requirements, use standard calibration for testing assays and report test results in a standard manner, make certain disclosures to ordering providers, and follow guidelines from certain organizations.